Page 3 - ஶரிஂக் ப்லௌ நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஶரிஂக் ப்லௌ நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஶரிஂக் ப்லௌ நிறுவனம் Today - Breaking & Trending Today

Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors
Reata Pharmaceuticals, Inc.April 15, 2021 GMT
PLANO, Texas, April 15, 2021 (GLOBE NEWSWIRE) Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced the appointments of Christy J. Oliger and Shamim Ruff to its Board of Directors, effective April 15, 2021.
“We are excited to welcome Ms. Ruff and Ms. Oliger to Reata’s board,” said Warren Huff, Reata’s Chief Executive Officer and President. “They join at a critical point in Reata’s development having just submitted our first New Drug Application for bardoxolone methyl (“bardoxolone”) for the treatment of chronic kidney disease caused by Alport syndrome. Both Ms. Ruff and Ms. Oliger bring a wealth of experience that will ....

United Kingdom , United States , Andres Lorente , Christyj Oliger , Manmeet Soni , University Of Loughborough , Sarepta Therapeutics Inc , Member Of The Royal Society Chemistry , Karyopharm Therapeutics Inc , University Of Leicester , Regulatory Affairs , Stoke Therapeutics Inc , Genentech Inc , Exchange Commission , University Of California At Santa Barbara , Reata Pharmaceuticals Inc , Amgen Inc , Plough Corporation , Abbott Laboratories , Roche Holding , Shamim Ruff , Warren Huff , Chief Executive Officer , New Drug Application , Schering Plough Corporation , Senior Vice President ,

Innocan Pharma Corporation: Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee


(0)
Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - April 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the Company or Innocan ) is proud to announce the addition of Richard Serbin
to its Advisory Committee. Richard Serbin will work closely with Innocan s leadership to address the emerging global Pharma opportunities, to expand Innocan s presence as part of its growth strategy, and to contribute from his extensive experience as Johnson & Johnson s Executive Vice President of Corporate Development, as former board member of more than 16 companies and, especially in regard to FDA regulations.
Richard Serbin
https://orders.newsfilecorp.com/files/6922/79561 51715afec4670a32 002full.jpg ....

Israel General , Tel Aviv , Iris Bincovich , Richard Serbin , Richard Serbinto , International Medical Communication Companies , Company Or Innocan , Advisory Committee , Liposome Research Of The Hebrew University , Innocan Pharma Corporation , Johnson Corporation , Corporate Development , Head Of The Laboratory Membrane , Innocan Pharma Ltd , Plough Corporation , Hebrew University Of Jerusalem , Alberta Newsfile Corp , Tel Aviv University , Pharma Corporation , Executive Vice President , Schering Plough Corporation , Revlon Healthcare , Bio Imaging Technologies , Advisory Board , Advisory Committeeis , Innocan Pharma ,